Nos combats

© Olivier Papegnies
We welcome the efforts of the global health actors and other stakeholders to rally financial support to the research and development (R&D), manufacturing and distribution of COVID-19 vaccines, diagnostics and therapeutics through the May 4th global pledging conference 1 .
Il existe un réel danger que l'accès aux avancées médicales concernant le COVID-19 soit limité. © Olivier Papegnies
COVID-19 has no nation and no ethnicity. If the pandemic goes unattended in one country, it will accelerate beyond that country’s borders, potentially overwhelming the world’s ability to respond.
© Reuters
On 3 July 2019, the organisations Doctors of the World and Public Eye, represented by Lionel Vial, filed a patent opposition at the European Patent Office against a patent covering Kymriah®, a gene therapy for cancer from Novartis, for which the French Social Security is billed €320,000 per patient...
The next generation of gene therapies used for treating cancer are now available on the market – with the first two CAR-T cell therapies priced at 320,000 and 350,000 euros. As was the case with hepatitis C drugs, these exorbitant prices reveal yet again the extent of the financialisation of the...
Funding and political support for harm reduction is in crisis in many countries around the world. Harm reduction is evidence-based, cost effective and has a positive impact on individual and community health. While harm reduction is far broader than HIV prevention, this call to action centres on...
On the final day of the Commission on Narcotic Drugs (CND), UN member states adopted the resolution "Promoting viral hepatitis prevention and treatment among people who have used drugs". During this plenary session, Wangari Kimenia, Head of Harm reduction for Doctors of the World in Kenya, spoke on...
Gilead’s price gouging for sofosbuvir blocks millions of people from getting treatment.
© Olivier Papegnies
Faced with significant price increases for new drugs, in North and South alike, particularly drugs for cancer, hepatitis C and rare diseases, civil society in France is taking action to defend access to best-quality care for all, and to safeguard the public healthcare system. Several organisations...
World Hepatitis Summit 2017 : Declaration of the Hepatitis Community.
 
Global loader